Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Sulfatinib

Base Information
  • Chemical Name:Sulfatinib
  • CAS No.:1308672-74-3
  • Molecular Formula:C24H28N6O3S
  • Molecular Weight:480.591
  • Hs Code.:
  • UNII:B2K5L1L8S9
  • NCI Thesaurus Code:C116066
  • Pharos Ligand ID:GC37HL8CV1KF
  • Metabolomics Workbench ID:155284
  • ChEMBL ID:CHEMBL4297190
  • Mol file:1308672-74-3.mol
Sulfatinib

Synonyms:N-(2-(dimethylamino)ethyl)-1-(3-((4-((2-methyl-1H-indol-5-yl)oxy)pyrimidin-2-yl)amino)phenyl)methanesulfonamide;surufatinib

Suppliers and Price of Sulfatinib
Supply Marketing:
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • TRC
  • Sulfatinib
  • 10mg
  • $ 340.00
  • TRC
  • Sulfatinib
  • 1mg
  • $ 60.00
  • DC Chemicals
  • Sulfatinib >98%
  • 10 mg
  • $ 400.00
  • DC Chemicals
  • Sulfatinib >98%
  • 50 mg
  • $ 1200.00
  • ChemScene
  • Sulfatinib 98.01%
  • 100mg
  • $ 450.00
  • ChemScene
  • Sulfatinib 98.01%
  • 1mg
  • $ 50.00
  • ChemScene
  • Sulfatinib 98.01%
  • 50mg
  • $ 290.00
  • ChemScene
  • Sulfatinib 98.01%
  • 10mg
  • $ 120.00
  • ChemScene
  • Sulfatinib 98.01%
  • 5mg
  • $ 90.00
Total 19 raw suppliers
Chemical Property of Sulfatinib
Chemical Property:
  • Boiling Point:712.9±70.0 °C(Predicted) 
  • PKA:5.22±0.40(Predicted) 
  • PSA:120.62000 
  • Density:1.332±0.06 g/cm3(Predicted) 
  • LogP:5.32790 
  • XLogP3:3.4
  • Hydrogen Bond Donor Count:3
  • Hydrogen Bond Acceptor Count:8
  • Rotatable Bond Count:10
  • Exact Mass:480.19435995
  • Heavy Atom Count:34
  • Complexity:733
Purity/Quality:

97% *data from raw suppliers

Sulfatinib *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:
Useful:
  • Canonical SMILES:CC1=CC2=C(N1)C=CC(=C2)OC3=NC(=NC=C3)NC4=CC=CC(=C4)CS(=O)(=O)NCCN(C)C
  • Recent ClinicalTrials:A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors
  • Recent EU Clinical Trials:An Open-Label Phase Ib/II Study of Surufatinib in Combination with Tislelizumab in Subjects With Advanced Solid Tumors
  • Recent NIPH Clinical Trials:Open-label study of surufatinib in Japanese patients
  • Uses Sulfatinib is used in pharmaceutical compositions comprising of micronized drug.
Technology Process of Sulfatinib

There total 1 articles about Sulfatinib which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1308672-74-3